BE902148A - Cephemes. - Google Patents

Cephemes.

Info

Publication number
BE902148A
BE902148A BE0/214810A BE214810A BE902148A BE 902148 A BE902148 A BE 902148A BE 0/214810 A BE0/214810 A BE 0/214810A BE 214810 A BE214810 A BE 214810A BE 902148 A BE902148 A BE 902148A
Authority
BE
Belgium
Prior art keywords
quaternary ammonio
cephemes
iminoacetamido
cephem
propen
Prior art date
Application number
BE0/214810A
Other languages
English (en)
Inventor
H Yamashita
M Oka
T Naito
J Okumura
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of BE902148A publication Critical patent/BE902148A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/08—1,2,4-Thiadiazoles; Hydrogenated 1,2,4-thiadiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/78—Separation; Purification; Stabilisation; Use of additives
    • C07C45/79—Separation; Purification; Stabilisation; Use of additives by solid-liquid treatment; by chemisorption

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

7-( 2-(5-Amino-1,2,4- thiadiazol-3-yl)-2-iminoacétamido (substitué) )-3-(3- (ammonio quaternaire)-1-propén-1-yl)-3-céphème-4-carboxylates de formule (I) ou R1 et R2 représentent des radicaux définis et -N==Q représente un radical ammonio quaternaire défini, outre leurs sels, solvates, hydrates et esters qui sont de puissants agents antibactériens. L'invention concerne aussi des procédés pour préparer ces composés et différents intremédiaires.
BE0/214810A 1984-04-09 1985-04-09 Cephemes. BE902148A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US59794184A 1984-04-05 1984-04-05

Publications (1)

Publication Number Publication Date
BE902148A true BE902148A (fr) 1985-10-09

Family

ID=24393575

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/214810A BE902148A (fr) 1984-04-09 1985-04-09 Cephemes.

Country Status (31)

Country Link
JP (4) JPS615084A (fr)
KR (1) KR870002166B1 (fr)
AR (1) AR244694A1 (fr)
AT (1) AT388735B (fr)
AU (2) AU580990B2 (fr)
BE (1) BE902148A (fr)
CA (3) CA1276929C (fr)
CH (1) CH669197A5 (fr)
DD (3) DD236735A5 (fr)
DE (1) DE3512225A1 (fr)
DK (1) DK155985A (fr)
ES (4) ES8607318A1 (fr)
FI (1) FI84830C (fr)
FR (1) FR2563832B1 (fr)
GB (3) GB2157293B (fr)
GR (1) GR850883B (fr)
HU (2) HU204277B (fr)
IE (2) IE58408B1 (fr)
IL (1) IL74826A (fr)
IT (1) IT1190353B (fr)
LU (1) LU85840A1 (fr)
MY (1) MY101940A (fr)
NL (1) NL192925C (fr)
NZ (1) NZ211659A (fr)
OA (1) OA07985A (fr)
PT (1) PT80246B (fr)
RU (1) RU2056425C1 (fr)
SE (4) SE466205B (fr)
SU (4) SU1487814A3 (fr)
YU (2) YU46151B (fr)
ZA (1) ZA852236B (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61145186A (ja) * 1984-12-20 1986-07-02 Meiji Seika Kaisha Ltd 新規セフエム化合物及びその製造法
US4708955A (en) * 1985-06-24 1987-11-24 Bristol-Myers Company 3-(substituted)propenyl-7-aminothiazol-ylcephalosporanic acids and esters thereof
ATE114657T1 (de) * 1985-12-26 1994-12-15 Eisai Co Ltd Cephalosporin-verbindungen.
IL84128A (en) * 1986-10-13 1992-12-01 Eisai Co Ltd 3-propenylcephem derivatives, their preparation and pharmaceutical compositions containing them
AU614723B2 (en) * 1986-10-13 1991-09-12 Eisai Co. Ltd. 3-propenylcephem derivative
JPH085897B2 (ja) * 1986-11-06 1996-01-24 エーザイ株式会社 ３−プロペニルセフェム誘導体
FR2622585B1 (fr) * 1987-11-03 1991-04-19 Roussel Uclaf Nouvelles cephalosporines comportant en position 3 un radical vinyle substitue, leur procede de preparation, leur application comme medicaments, les compositions les renfermant et les nouveaux intermediaires obtenus
JPH0699449B2 (ja) * 1988-03-16 1994-12-07 エーザイ株式会社 セフェム誘導体の合成中間体
DE68928174T2 (de) * 1988-03-16 1997-12-18 Eisai Co., Ltd., Tokio/Tokyo Verfahren zur Herstellung von Cephemderivaten
FR2655042B1 (fr) * 1989-11-29 1994-01-21 Adir Cie Nouvelles benzothiazolinones substituees, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
FR2663332B1 (fr) * 1990-06-15 1997-11-07 Roussel Uclaf Nouvelles cephalosporines comportant en position 3 un radical propenyle substitue par un ammonium quaternaire, leur procede de preparation, leur application comme medicaments, les compositions les renfermant et les nouveaux intermediaires obtenus.
US5126336A (en) * 1990-08-23 1992-06-30 Bristol-Myers Squibb Company Antibiotic c-3 catechol-substituted cephalosporin compounds, compositions and method of use thereof
AT396108B (de) * 1991-08-21 1993-06-25 Biochemie Gmbh Neues verfahren und neue zwischenprodukte zur herstellung von 7-aminocephalosporansaeurederivaten
JPH0741484A (ja) * 1993-07-29 1995-02-10 Katayama Seiyakushiyo:Kk セフェム化合物及び抗菌剤
KR100248851B1 (ko) * 1994-08-16 2000-04-01 이치로 키타사토 신규 세펨 유도체
AU761450B2 (en) 1998-06-22 2003-06-05 Basilea Pharmaceutica Ag Propenyl cephalosporin derivatives
US7507812B2 (en) 2003-09-09 2009-03-24 Nippon Chemical Industrial Co., Ltd. Process for producing 3-chloromethyl-3-cephem derivatives

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1342241A (en) * 1970-01-23 1974-01-03 Glaxo Lab Ltd Cephalosporin compounds
US4390534A (en) * 1978-12-29 1983-06-28 Fujisawa Pharmaceutical Co., Ltd. Cephem and cepham compounds
EP0025017A1 (fr) * 1979-08-28 1981-03-11 Ciba-Geigy Ag Composés polyazathia, procédé pour leur préparation, compositions pharmaceutiques les contenant et utilisation de ces dernières
US4409214A (en) * 1979-11-19 1983-10-11 Fujisawa Pharmaceutical, Co., Ltd. 7-Acylamino-3-vinylcephalosporanic acid derivatives and processes for the preparation thereof
GR75644B (fr) * 1980-06-18 1984-08-02 Fujisawa Pharmaceutical Co
GR78245B (fr) * 1980-09-12 1984-09-26 Ciba Geigy Ag
US4521413A (en) * 1981-09-14 1985-06-04 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
US4486586A (en) * 1983-02-10 1984-12-04 Bristol-Myers Company Cephalosporin derivatives

Also Published As

Publication number Publication date
SE8901226D0 (sv) 1989-04-06
HUT37622A (en) 1986-01-23
SE8501680D0 (sv) 1985-04-03
AU2504188A (en) 1989-03-02
GB2157293A (en) 1985-10-23
IE58408B1 (en) 1993-09-22
GB2194790B (en) 1988-10-05
DD236735A5 (de) 1986-06-18
ZA852236B (en) 1985-11-27
SE8901224D0 (sv) 1989-04-06
SE470260B (sv) 1993-12-20
JPS61143390A (ja) 1986-07-01
RU2056425C1 (ru) 1996-03-20
FR2563832A1 (fr) 1985-11-08
SU1367858A3 (ru) 1988-01-15
GR850883B (fr) 1985-11-25
DE3512225C2 (fr) 1990-02-22
FI851379L (fi) 1985-10-10
JPS61143391A (ja) 1986-07-01
ES551550A0 (es) 1987-06-01
GB2194790A (en) 1988-03-16
PT80246A (en) 1985-05-01
SE505256C2 (sv) 1997-07-21
SE466205B (sv) 1992-01-13
OA07985A (fr) 1987-01-31
ES542013A0 (es) 1986-06-16
HU193750B (en) 1987-11-30
CA1340672C (fr) 1999-07-20
AT388735B (de) 1989-08-25
NL192925B (nl) 1998-01-05
ES8706694A1 (es) 1987-07-01
ES551551A0 (es) 1987-07-01
SE8901224L (sv) 1989-04-06
ATA103985A (de) 1989-01-15
IL74826A0 (en) 1985-07-31
SU1375140A3 (ru) 1988-02-15
NL8501002A (nl) 1985-11-01
GB8721346D0 (en) 1987-10-14
IL74826A (en) 1990-01-18
AU610278B2 (en) 1991-05-16
GB2194789A (en) 1988-03-16
ES8706155A1 (es) 1987-06-01
ES557060A0 (es) 1987-12-01
DD251752A5 (de) 1987-11-25
CA1340638C (fr) 1999-07-06
YU118987A (en) 1988-10-31
DE3512225A1 (de) 1985-10-17
SU1436882A3 (ru) 1988-11-07
FR2563832B1 (fr) 1989-08-18
SE8901225D0 (sv) 1989-04-06
KR850007424A (ko) 1985-12-04
AU4086285A (en) 1985-10-17
SE8901225L (sv) 1989-04-06
PT80246B (pt) 1987-10-20
AU580990B2 (en) 1989-02-09
CH669197A5 (de) 1989-02-28
ES8800949A1 (es) 1987-12-01
YU60085A (en) 1987-12-31
MY101940A (en) 1992-02-15
LU85840A1 (fr) 1985-12-16
JPH0357106B2 (fr) 1991-08-30
NL192925C (nl) 1998-05-07
FI84830C (fi) 1992-01-27
DK155985D0 (da) 1985-04-03
AR244694A1 (es) 1993-11-30
GB8508846D0 (en) 1985-05-09
SE8501680L (sv) 1985-10-10
DD249024A5 (de) 1987-08-26
JPH0350754B2 (fr) 1991-08-02
IT1190353B (it) 1988-02-16
FI851379A0 (fi) 1985-04-04
CA1276929C (fr) 1990-11-27
GB2157293B (en) 1988-10-05
ES8607318A1 (es) 1986-06-16
SE470259B (sv) 1993-12-20
JPH0351716B2 (fr) 1991-08-07
IE58403B1 (en) 1993-09-22
IE850866L (en) 1985-10-09
JPH0262557B2 (fr) 1990-12-26
YU46213B (sh) 1993-05-28
KR870002166B1 (ko) 1987-12-14
JPS615084A (ja) 1986-01-10
FI84830B (fi) 1991-10-15
DK155985A (da) 1985-10-10
GB2194789B (en) 1988-10-12
SE8901226L (sv) 1989-04-06
SU1487814A3 (ru) 1989-06-15
GB8721347D0 (en) 1987-10-14
IT8520267A0 (it) 1985-04-05
YU46151B (sh) 1993-05-28
HU204277B (en) 1991-12-30
NZ211659A (en) 1988-11-29
JPS61143387A (ja) 1986-07-01

Similar Documents

Publication Publication Date Title
BE902148A (fr) Cephemes.
MY8700709A (en) 3-aryloxy-3-phenylprophylamines
LU90159I2 (fr) Difloxacin optionnellement sous forme d'un sel ou ester pharmaceutique
YU33286A (en) Process for obtaining trisubstituted benzo acids
PT918776E (pt) Sintese total de acilfulvenos antitumorais
DE69131325D1 (de) Zwischenverbindungen zur herstellung von thioalkylthio cephalosporinderivaten
ES2054806T3 (es) Cicloalquilamidas de (8beta)-1-alquil-6-(sustituido)-ergolinas.
SE8901032D0 (sv) Mellanprodukter foer framstaellning av karbapenemderivat
GB8706662D0 (en) Anti-arrhythmia agents
AU603232B2 (en) Herbicidal agents
FR2531711B1 (fr)
GR861512B (en) Benzaldoxim-carbamat-derivatives
ZA817670B (en) 2-(n-aryl,n-1,2,3-thiadiazolylcarbonyl)-aminobutyrolactones,their preparation,fungicidal agents containing these compounds,and their use as fungicides
FR2396011A1 (fr) Nouvelles 2,3-dihydro-1,4-benzoxathines pour inhibition de lipogenese

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: *BRISTOL-MYERS CY

Effective date: 20050409

RE20 Patent expired

Owner name: *BRISTOL-MYERS CY

Effective date: 20050409